OIG faults noncompliant drug billing for Medicare overpaymentsFierceHealthcareJohnston Memorial Hospital in Abingdon, Va., did not follow federal rules in billing Medicare for 31 reviewed items involving drug injections (doxorubicin hydrochloride lipos…
Dr Reddy's bets big on biosimilars, eyes regulated marketsEconomic TimesAt present, DRL's biosimilars portfolio includes filgrastim, peg-filgrastim, rituximab and darbepoetin alfa, which have commercial presence in 13 countries among emerging m…
Sports fun day to raise cash for patient's drugsDerby TelegraphHer family and friends have raised thousands of pounds towards the cost of a drug called Rituximab which is not available on the NHS in the East Midlands and costs £25000 a year. On Sa…
Plan Set for Charlie's Second Stem Cell TransplantWGBA-TVAfter weeks of pain and discomfort, doctors at Children's Hospital in Minneapolis have started the medication Rituximab designed to help Charlie's stomach feel better. Trisha Knuth wr…
One-quarter of ITP patients achieve 5-year treatment-free responseNews-Medical.netApproximately 25% of patients with immune thrombocytopenia purpura who receive treatment with rituximab maintain a treatment-free response lasting for at least 5 years, s…
Daily MailParched and tired all the time? You could have 'dry body' syndromeDaily MailDr Bowman is leading a £1 million clinical trial on behalf of Arthritis Research UK looking at the drug Rituximab. This is licensed to treat severe rheumatoi…
Storm Davis UpdateFranklin News PostCheyenne Storm Davis, 13, of Callaway must spend a month waiting for the results from a Rituximab treatment before learning if she is eligible for another kidney transplant. The teen, who has had kidney problems sinc…
Dr Reddy's plans to launch biosimilars in developed marketsHindu Business LineAt present, the biosimilar portfolio of the Hyderabad-based company comprises Filgrastim, peg-filgrastim, Rituximab and Darbepoetin alfa. Dr Reddy's global biosimilar…
Janssen-Cilag International withdraws application for Velcade (bortezomib)Express PharmaJanssen-Cilag International NV on September 2, 2011, submitted an application to extend the marketing authorisation for Velcade in combination with rituximab for th…
J&J pulls file to extend Velcade's use in EUPharma TimesThe drugmaker was seeking approval for the use of Velcade in combination with rituximab as a treatment for patients with relapsed follicular non-Hodgkin lymphoma. However, in a statement r…